TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$4.16M 0.15%
300,611
127
$4.15M 0.15%
42,479
128
$4.13M 0.15%
+5,000
129
$4.03M 0.14%
80,760
+61,360
130
$3.96M 0.14%
81,554
-300,366
131
$3.93M 0.14%
607,698
132
$3.83M 0.13%
210,146
133
$3.82M 0.13%
531,570
134
$3.79M 0.13%
76,548
135
$3.62M 0.13%
18,116
136
$3.5M 0.12%
10,812
-1,400
137
$3.5M 0.12%
61,370
138
$3.39M 0.12%
169,930
139
$3.3M 0.12%
82,736
-14,000
140
$3.27M 0.12%
98,387
141
$3.08M 0.11%
67,682
142
$3.08M 0.11%
104,024
143
$3.07M 0.11%
12,029
-5,510
144
$2.96M 0.1%
714,008
145
$2.78M 0.1%
131,183
146
$2.71M 0.1%
+250,000
147
$2.64M 0.09%
55,938
148
$2.63M 0.09%
20,000
149
$2.63M 0.09%
18,871
150
$2.57M 0.09%
31,591
4 5
6
7 8